David Calkins

Professor, Vice Chairman, and Director

Vanderbilt University Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Calkins is a Professor, Vice Chairman, and Director at Vanderbilt University Medical Center in the United States. His research focuses on neurodegeneration, specifically in the context of glaucoma, exploring mechanisms, challenges, and potential treatments. Recent articles include studies on retinal astrocyte responses and novel collagen mimetic peptides for ocular conditions.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Michael L. Risner

Research Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Ameer Haider

Washington University in St. Louis

UNITED STATES

View details

Don Zack

Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Calkins

Research Interests

Explore related searches

Contact this professor

About

Articles (24)

Cover Image, Volume 73, Issue 7

Potassium‐Dependent Coupling of Retinal Astrocyte Light Response to Müller Glia

Topical Application of a Collagen Mimetic Peptide Restores Peripapillary Scleral Stiffness Reduced by Ocular Stress

Bilateral astrocyte reaction to unilateral insult in the optic projection to the brain

Cover Image, Volume 72, Issue 7

Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments

A Phase 2 Trial to Test Safety and Efficacy of ST-100, a Unique Collagen Mimetic Peptide Ophthalmic Solution for Dry Eye Disease

A Phase 2 Trial to Test Safety and Efficacy of ST-100, a Unique Collagen Mimetic Peptide Ophthalmic Solution for Dry Eye Disease

Collagen in the central nervous system: contributions to neurodegeneration and promise as a therapeutic target

Collagen in the central nervous system: contributions to neurodegeneration and promise as a therapeutic target

Morphological and electrophysiological characterization of a novel displaced astrocyte in the mouse retina

Morphological and electrophysiological characterization of a novel displaced astrocyte in the mouse retina

Ocular stress enhances contralateral transfer of lenadogene nolparvovec gene therapy through astrocyte networks

Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway

Collagen Mimetic Peptides Promote Repair of MMP-1-Damaged Collagen in the Rodent Sclera and Optic Nerve Head

Collagen Mimetic Peptides Promote Repair of MMP-1-Damaged Collagen in the Rodent Sclera and Optic Nerve Head

Ex Vivo Integration of Human Stem Retinal Ganglion Cells into the Mouse Retina

Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma

Dysfunctional cGMP Signaling Leads to Age-Related Retinal Vascular Alterations and Astrocyte Remodeling in Mice

Sensitivity to extracellular potassium underlies type-intrinsic differences in retinal ganglion cell excitability

Collagen Mimetic Peptides Promote Adherence and Migration of ARPE-19 Cells While Reducing Inflammatory and Oxidative Stress

Intraocular Delivery of a Collagen Mimetic Peptide Repairs Retinal Ganglion Cell Axons in Chronic and Acute Injury Models

Corneal collagen as a potential therapeutic target in dry eye disease

Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primates

Collaborators (3)

Michael L. Risner

Ameer Haider

Don Zack

Make your next move.